EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Recent Searches
Office
Nashville, United States
With over 30 years of experience in consulting and industry roles, Kim Dalla Torre is shaping the future of health care as EY Global and Americas Health Leader, helping to steer the strategic direction of her clients; craft innovative practice strategies; and manage service delivery that spans consulting, audit, tax and transaction services.
Along her professional journey, Kim has been dedicated to innovation and strategic growth. She has a rich history of managing transformation programs and pioneering solution innovation, catering to a broad spectrum of industry players, including health payers, health providers, pharmaceuticals and medical technology companies.
The cornerstones of her work include analytics, health informatics, commercial strategy and operations, and she has been called upon to direct complex, large-scale business transformation projects for some of the world’s leading companies.
Kim graduated from Middle Tennessee State University with a BBA in Computer Information Systems and is named in four solution patents.
How Kim is building a better working world
“No sector directly impacts our quality of life, at some of our most vulnerable moments, more than health care. My focus is on nurturing a culture of excellence, fostering innovation, and facilitating collaboration to address the dynamic needs of our clients and the industry at large.
For instance, I have led the development and commercialization of life sciences solutions for health informatics, as well as the strategy, design and implementation of multiyear global program to transform commercial operations for a top 20 pharmaceutical company.
And I facilitated the development of a consortium model with one of the top tree academic medical centers, two pharmaceutical companies and two payer organizations to pilot safety surveillance, comparative effectiveness and custom studies.
By empowering care through technology with innovative and practical approaches, I’m dedicated to building a future where better health is in everyone’s reach.”
